Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibandronate for Bone Marrow Edema in Knee Osteonecrosis
NCT00532220Phase 3Completed
- Sponsor
- University Hospital Basel
- Start
- Dec 2007
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibandronate in osteonecrosis of the knee, bone marrow edema (BME), sponsored by University Hospital Basel. Started Dec 2007; status: completed.
02
Drugs
ibandronate
03
Conditions
osteonecrosis of the kneebone marrow edema (BME)
Beyond the preview
Go deeper on NCT00532220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532220.